XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort

Clinical trial NCT01106534 · COMPLETED

Trial details

NCT number: NCT01106534
Sponsor: Abbott Medical Devices
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Total Occlusion of Coronary Artery Vascular Disease Myocardial Ischemia Coronary Artery Stenosis Coronary Disease Coronary Artery Disease Coronary Restenosis

Start date: 2009-08-01
Primary completion: 2015-02-01
Enrollment: 870

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.